J. Zager

R. Gonzalez, M. Bui, J. Zager, 2013, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Limb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasms.

R. Gonzalez, K. Delman, D. Tyler, 2011, Archives of surgery.

Single cell characterization of the cellular landscape of acral melanoma identifies novel targets for immunotherapy.

V. Sondak, F. Karreth, K. Smalley, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Metastatic melanoma patients’ sensitivity to ipilimumab cannot be predicted by tumor characteristics

T. Olencki, E. Hade, A. Gangi, 2017, International journal of surgery. Oncology.

Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis

James X. Sun, J. Stein, I. Osman, 2021, Cancer control : journal of the Moffitt Cancer Center.

An evaluation of talimogene laherparepvec for the treatment of melanoma

J. Zager, K. Broman, 2020, Expert opinion on biological therapy.

Relationship between age and likelihood of lymph node metastases in patients with intermediate thickness melanoma (1.01-4.00 mm): A National Cancer Database study.

D. Elder, D. Fraker, B. Pockaj, 2019, Journal of the American Academy of Dermatology.

Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter Study

V. Sondak, R. Scolyer, S. Lo, 2022, Annals of Surgical Oncology.

Regional therapy in metastatic melanoma: an update on minimally invasive intraarterial isolated limb infusion and percutaneous hepatic perfusion

J. Zager, S. Sloot, O. Rashid, 2014, Expert opinion on drug metabolism & toxicology.

Effect of murine liver cell proliferation on herpes viral behavior: Implications for oncolytic viral therapy

N. Gusani, K. Delman, Y. Fong, 2004, Hepatology.

Therapy for unresectable recurrent and in-transit extremity melanoma.

K. Delman, J. Zager, M. Gimbel, 2008, Cancer control : journal of the Moffitt Cancer Center.

Comparison of Single-Photon Emission Computed Tomography–Computed Tomography (SPECT/CT) and Conventional Planar Lymphoscintigraphy for Sentinel Node Localization in Patients with Cutaneous Malignancies

V. Sondak, J. Zager, N. Patel, 2017, Annals of Surgical Oncology.

Chemosaturation With Percutaneous Hepatic Perfusion in Unresectable Hepatic Metastases.

J. Zager, Evan S. Glazer, E. Glazer, 2017, Cancer control : journal of the Moffitt Cancer Center.

Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.

A. Gesierich, R. Dummer, R. Scolyer, 2022, JAMA surgery.

Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience

James X. Sun, K. Delman, D. Ollila, 2021, Annals of Surgical Oncology.

Current approaches to cutaneous sarcomas: Dermatofibrosarcoma protuberans and cutaneous leiomyosarcoma.

J. Zager, Evan S. Glazer, C. Prieto-Granada, 2015, Current problems in cancer.

Cutaneous Angiosarcoma: A Single-Institution Experience

V. Sondak, T. Padhya, R. Gonzalez, 2013, Annals of Surgical Oncology.

Current diagnosis and management of retroperitoneal sarcoma.

John E. Mullinax, R. Gonzalez, J. Zager, 2011, Cancer control : journal of the Moffitt Cancer Center.

Multidisciplinary management of special melanoma situations: Oligometastatic disease and bulky nodal sites

V. Sondak, J. Zager, A. Sarnaik, 2007, Current oncology reports.

Dermatofibrosarcoma Protuberans: How Wide Should We Resect?

V. Sondak, M. Bui, M. Sabel, 2010, Annals of Surgical Oncology.

Proper Margins of Excision in Dermatofibrosarcoma Protuberans: Wide or Narrow?

V. Sondak, M. Bui, J. Messina, 2008, Annals of Surgical Oncology.

Regression is significantly associated with outcomes for patients with melanoma.

V. Sondak, B. Pockaj, J. Messina, 2021, Surgery.

Interleukin 12 Secretion Enhances Antitumor Efficacy of Oncolytic Herpes Simplex Viral Therapy for Colorectal Cancer

K. Delman, R. Wong, Y. Fong, 2001, Annals of surgery.

Pediatric melanoma: Analysis of an international registry

D. Jukic, V. Sondak, S. Swetter, 2013, Cancer.

Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer

K. Delman, H. Federoff, Y. Fong, 2002, Cancer Gene Therapy.

Replication-competent herpes virus NV1020 as direct treatment of pleural cancer in a rat model.

V. Rusch, K. Delman, Y. Fong, 2002, The Journal of thoracic and cardiovascular surgery.

Combination Vascular Delivery of Herpes Simplex Oncolytic Viruses and Amplicon Mediated Cytokine Gene Transfer Is Effective Therapy for Experimental Liver Cancer

K. Delman, M. Halterman, H. Federoff, 2001, Molecular medicine.

Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial

M. Ross, K. Delman, I. Puzanov, 2016, Annals of Surgical Oncology.

Regional therapies for locoregionally advanced and unresectable melanoma

J. Zager, E. Weitman, 2018, Clinical & Experimental Metastasis.

The safety of talimogene laherparepvec for the treatment of advanced melanoma

A. Gangi, J. Zager, 2016, Expert opinion on drug safety.

ASO Author Reflections: T-VEC as Salvage for Progression of Locoregionally Metastatic Melanoma After Failure of Immunotherapy

J. Zager, Michael J. Carr, 2021, Annals of Surgical Oncology.

Observational study of talimogene laherparepvec use in the anti-PD-1 era for melanoma in the US (COSMUS-2)

James X. Sun, I. Puzanov, R. Carvajal, 2020, Melanoma management.

The emergence of neoadjuvant therapy in advanced melanoma

James X. Sun, J. Zager, Z. Eroglu, 2019, Melanoma management.

The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma

J. Zager, G. Beasley, J. Thompson, 2019, Annals of Surgical Oncology.

Observational study of talimogene laherparepvec use for melanoma in clinical practice in the United States (COSMUS-1)

J. Kirkwood, C. Ariyan, J. Zager, 2019, Melanoma management.

ASO Author Reflections: International Experience of Isolated Limb Infusion for Melanoma Shows Durable Response

J. Zager, J. Miura, H. Kroon, 2019, Annals of Surgical Oncology.

Intussusception: An Uncommon Cause of Postoperative Small Bowel Obstruction after Gastric Bypass

J. Zager, J. Vasile, Elliot R. Goodman, 2004, Obesity surgery.

99mTc-tilmanocept for lymphoscintigraphy

V. Sondak, C. Berman, J. Zager, 2013 .

Sentinel lymph node biopsy in melanoma: beyond histologic factors

F. Monzon, J. Zager, Michael J. Carr, 2021, Clinical & Experimental Metastasis.

Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on Survival

V. Sondak, B. Pockaj, J. Messina, 2019, Annals of Surgical Oncology.

Review of diagnostic, prognostic, and predictive biomarkers in melanoma

J. Messina, J. Luke, J. Zager, 2018, Clinical & Experimental Metastasis.

Patterns of histologic response to neoadjuvant targeted therapy in patients with BRAF mutant melanoma.

V. Sondak, J. Messina, J. Markowitz, 2017 .

Granular cell tumor—A unique neoplasm of the internal anal sphincter

J. Zager, J. Garbus, Matthew G. Cohen, 2000, Diseases of the colon and rectum.

Granular Cell Tumor—A Unique Neoplasm of the Internal Anal Sphincter: Report of a Case

J. Zager, J. Garbus, Matthew G. Cohen, 2000 .

Sentinel node biopsy in atypical melanocytic neoplasms in childhood: a single institution experience in 24 patients

V. Sondak, J. Messina, J. Zager, 2012, Journal of cutaneous pathology.

Shave biopsy is a safe and accurate method for the initial evaluation of melanoma.

V. Sondak, J. Messina, S. Hochwald, 2011, Journal of the American College of Surgeons.

Stratifying SLN incidence in intermediate thickness melanoma patients.

V. Sondak, B. Pockaj, J. Messina, 2017, American journal of surgery.

Merkel cell carcinoma: pathologic findings and prognostic factors.

V. Sondak, J. Messina, J. Zager, 2010, Current problems in cancer.

Surgical Management of Melanoma-In-Situ Using a Staged Marginal and Central Excision Technique

Graham S. Clark, V. Sondak, Daohai Yu, 2009, Annals of Surgical Oncology.

The surgical management of primary and metastatic Merkel cell carcinoma.

V. Sondak, T. Padhya, R. Gonzalez, 2010, Current problems in cancer.

Merkel Cell Carcinoma of Unknown Primary Origin

V. Sondak, R. Gonzalez, J. Messina, 2012, Annals of Surgical Oncology.

Controversies in the evaluation and management of atypical melanocytic proliferations in children, adolescents, and young adults.

V. Sondak, J. Messina, R. Kudchadkar, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma

V. Sondak, T. Strom, J. Torres-Roca, 2016, Annals of Surgical Oncology.

Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.

J. Kirkwood, G. Lyman, A. Cochran, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Future perspectives: Novel Frontiers in Cancer Metastasis

S. Leong, J. Zager, 2022, Clinical & experimental metastasis.

Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma

J. Zager, James M. Lewis, S. Dessureault, 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma.

V. Sondak, T. Strom, S. Eschrich, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients

J. Ho, L. Ferris, K. Covington, 2018, BMC Cancer.

Pathology review of thin melanoma and melanoma in situ in a multidisciplinary melanoma clinic: impact on treatment decisions.

V. Sondak, J. Messina, J. Zager, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Occult primary.

D. Ettinger, A. Rashid, L. Kvols, 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

Progression of cutaneous melanoma: implications for treatment

A. Hauschild, V. Sondak, M. Mihm, 2012, Clinical & Experimental Metastasis.

Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?

V. Sondak, R. Gonzalez, J. Messina, 2018, Annals of Surgical Oncology.

Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma.

Jacob G. Scott, R. Gonzalez, M. Bui, 2016, Brachytherapy.

Breast and Soft Tissue Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma

Jacob G. Scott, R. Gonzalez, M. Bui, 2016 .

ASO Author Reflections: Resection Margins in Merkel Cell Carcinoma: Is a 1 cm Margin Wide Enough?

J. Zager, M. Perez, 2018, Annals of Surgical Oncology.

Is a Wider Margin (2 cm vs. 1 cm) for a 1.01–2.0 mm Melanoma Necessary?

V. Sondak, R. Gonzalez, J. Messina, 2016, Annals of Surgical Oncology.

Clinical Characteristics and Outcomes for Solitary Fibrous Tumor (SFT): A Single Center Experience

V. Sondak, R. Gonzalez, M. Bui, 2015, PloS one.

Sentinel lymph node mapping in melanoma in the twenty-first century.

J. Zager, M. Doepker, 2015, Surgical oncology clinics of North America.

Genetic Testing in the Multidisciplinary Management of Melanoma.

J. Zager, O. Rashid, 2015, Surgical oncology clinics of North America.

Three Cases of Small Bowel Intussusception in Relation to a Rare Lesion: Inflammatory Fibrous Polyps

J. Zager, J. Kaufman, G. Denoto, 2001, Digestive Surgery.

Jejunal Diverticulosis: A Rare Entity with Multiple Presentations, a Series of Cases

J. Zager, S. Garber, J. Shaw, 2001, Digestive Surgery.

Pelvic Exenteration Affords Safe and Durable Treatment for Locally Advanced Rectal Carcinoma

C. Wood, J. Skibber, B. Feig, 2007, Annals of Surgical Oncology.

Intralesional and systemic immunotherapy for metastatic melanoma

J. Zager, N. Khushalani, C. Luu, 2016, Expert opinion on biological therapy.

Letter Regarding Editorial by Samuel Zagarella.

P. Ascierto, A. Cochran, C. Blank, 2020, The American Journal of dermatopathology.

Isolated Limb Perfusion and Infusion for Extremity Soft Tissue Sarcoma: A Contemporary Systematic Review and Meta-Analysis

D. Fraker, A. Sinnamon, J. Zager, 2017, Annals of Surgical Oncology.

Recent developments in the medical and surgical treatment of melanoma

R. Kudchadkar, J. Zager, C. Ambe, 2014, CA: a cancer journal for clinicians.

Treatment of Head and Neck Melanoma In Situ With Staged Contoured Marginal Excisions

V. Sondak, J. Messina, J. Zager, 2017, Annals of plastic surgery.

Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)

V. Sondak, M. Ross, K. Shannon, 2022, Annals of Surgical Oncology.

Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node‐negative melanoma

V. Sondak, J. Messina, K. Fisher, 2015, Cancer.

Clinicopathologic Predictors of Survival in Patients with Desmoplastic Melanoma

V. Sondak, J. Messina, J. Zager, 2015, PloS one.

Radiotherapy influences local control in patients with desmoplastic melanoma

V. Sondak, T. Strom, Daohai Yu, 2014, Cancer.

Lymphoscintigraphy Using Tilmanocept Detects Multiple Sentinel Lymph Nodes in Melanoma Patients

M. Nosrati, E. Vaquero, M. Kashani-Sabet, 2023, Cancer control : journal of the Moffitt Cancer Center.

Intralesional therapy for metastatic melanoma

J. Zager, S. Sloot, O. Rashid, 2014, Expert opinion on pharmacotherapy.

Molecular Aspects of the Isolated Limb Infusion Procedure

J. Zager, H. Kroon, Michael J. Carr, 2021, Biomedicines.

Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia

James X. Sun, K. Delman, D. Tyler, 2020, Annals of Surgical Oncology.

Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study.

James X. Sun, K. Delman, D. Tyler, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Isolated limb infusion: Institutional protocol and implementation

James X. Sun, J. Zager, Michael J. Carr, 2020, Journal of surgical oncology.

International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients

James X. Sun, K. Delman, D. Tyler, 2020, Annals of Surgical Oncology.

Infusion Technique

J. Zager, J. Farma, G. Gauvin, 2019, Cancer Regional Therapy.

Local and Recurrent Regional Metastases of Melanoma

C. Ariyan, K. Tanabe, J. Zager, 2019, Cutaneous Melanoma.

Long–Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis

James X. Sun, K. Delman, D. Tyler, 2019, Annals of Surgical Oncology.

Isolated Limb Perfusion and Infusion in the Management of In-Transit Melanoma of the Extremities: Modern Data Affecting Practice

J. Zager, J. Ankeny, 2019 .

Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma.

Merrick I Ross, Stephen R Grobmyer, M. Ross, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary Tumor Thickness as a Prognostic Factor in Merkel Cell Carcinoma: The Next Big Thing?

V. Sondak, J. Messina, J. Zager, 2012, Annals of Surgical Oncology.

Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model.

W. Jarnagin, K. Delman, M. Brennan, 2000, Annals of surgery.

Regression in melanoma is significantly associated with a lower regional recurrence rate and better recurrence‐free survival

V. Sondak, B. Pockaj, J. Messina, 2021, Journal of surgical oncology.

Laparoscopic appendectomy for Crohn's disease of the appendix presenting as acute appendicitis.

N. Gusani, B. Derubertis, J. Zager, 2001, Journal of laparoendoscopic & advanced surgical techniques. Part A.

1095TiP Daromun, a dermato-oncology drug in development for stage III and IV melanoma and non-melanoma skin cancers: A clinical overview

K. Kähler, J. Zager, D. Neri, 2021, Annals of Oncology.

Limiting the morbidity of inguinal lymphadenectomy for metastatic melanoma.

V. Sondak, J. Zager, C. Puleo, 2009, Cancer control : journal of the Moffitt Cancer Center.

Microsatellitosis in Patients with Melanoma

V. Sondak, P. Gimotty, B. Pockaj, 2018, Annals of Surgical Oncology.

A comparison between patients with gastrointestinal stromal tumours diagnosed with isolated liver metastases and liver metastases plus sarcomatosis.

R. Gonzalez, S. G. de la Fuente, J. Zager, 2013, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Dermal melanoma: A report on prognosis, outcomes, and the utility of sentinel lymph node biopsy

V. Sondak, K. Egan, R. Gonzalez, 2016, Journal of surgical oncology.

Sentinel lymph node biopsy in melanoma: beyond histologic factors

F. Monzon, J. Zager, Michael J. Carr, 2021, Clinical & Experimental Metastasis.

Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart review

J. Utikal, Y. Najjar, C. Robert, 2019, Melanoma management.

Occult primary, version 3.2014; Featured updates to the NCCN guidelines

D. Ettinger, A. Rashid, D. Gierada, 2014 .

Occult primary, version 3.2014.

D. Ettinger, A. Rashid, D. Gierada, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma.

J. Utikal, D. Schadendorf, V. Sondak, 2017, European journal of cancer.

Outcomes and clinical predictors of improved survival in a patients undergoing pulmonary metastasectomy for sarcoma

Lesly A. Dossett, R. Gonzalez, J. Zager, 2015, Journal of surgical oncology.

CO20. Percutaneous hepatic perfusion (PHP) for metastatic melanoma: results from a single institution

J. Zager, 2011 .

Isolated Limb Infusion: A Single-Center Experience with Over 200 Infusions

R. Gonzalez, J. Zager, Youngchul Kim, 2017, Annals of Surgical Oncology.

Metastatic melanoma to the liver: A contemporary and comprehensive review of surgical, systemic, and regional therapeutic options

S. O’Day, J. Zager, S. Agarwala, 2014, Cancer.

Cancer Regional Therapy: HAI, HIPEC, HILP, ILI, PIPAC and Beyond

T. Gamblin, J. Zager, Byrne Lee, 2020 .

The MAP kinase signal transduction pathway: promising therapeutic targets used in the treatment of melanoma

J. Zager, E. McClure, Michael J. Carr, 2020, Expert review of anticancer therapy.

An evaluation of encorafenib for the treatment of melanoma

James X. Sun, J. Zager, Z. Eroglu, 2019, Expert opinion on pharmacotherapy.

Update on BRAF and MEK inhibition for treatment of melanoma in metastatic, unresectable, and adjuvant settings

James X. Sun, Lesly A. Dossett, J. Zager, 2019, Expert opinion on drug safety.

Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy

James X. Sun, J. Zager, Z. Eroglu, 2018, OncoTargets and therapy.

Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma

Lesly A. Dossett, J. Zager, R. Olofsson Bagge, 2016, Annals of Surgical Oncology.

BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategy

V. Sondak, R. Gonzalez, G. Gibney, 2016, Melanoma research.

BRAF and MEK inhibition in melanoma

Lesly A. Dossett, R. Kudchadkar, J. Zager, 2015, Expert opinion on drug safety.

Is the presence of tumor‐infiltrating lymphocytes predictive of outcomes in patients with melanoma?

V. Sondak, B. Pockaj, J. Messina, 2022, Cancer.

Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node Dissection

James X. Sun, V. Sondak, M. Schabath, 2021, Annals of Surgical Oncology.

In-transit metastatic cutaneous melanoma: current management and future directions

James X. Sun, J. Zager, Michael J. Carr, 2021, Clinical & Experimental Metastasis.

Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT‐2)

James X. Sun, Lesly A. Dossett, V. Sondak, 2021, Cancer.

Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era

James X. Sun, V. Sondak, Dennie T. Frederick, 2020, Annals of Surgical Oncology.

Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience

V. Sondak, T. Strom, J. Torres-Roca, 2018, Melanoma management.

In-transit metastatic cutaneous melanoma: current management and future directions

James X. Sun, J. Zager, Michael J. Carr, 2021, Clinical & Experimental Metastasis.

Treatment options for limited or symptomatic metastatic melanoma.

V. Sondak, J. Mcloughlin, L. Berk, 2008, Cancer Control: Journal of the Moffitt Cancer Cente.

Is There a Relationship Between TILs and Regression in Melanoma?

B. Pockaj, J. Messina, M. Kashani-Sabet, 2022, Annals of Surgical Oncology.

Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

B. Pockaj, S. Leong, J. Zager, 2016, World journal of clinical oncology.

Sentinel Node Biopsy is Indicated for Thin Melanomas ≥0.76 mm

V. Sondak, Daohai Yu, R. Gonzalez, 2012, Annals of Surgical Oncology.

Profound proliferating angiolymphoid hyperplasia with eosinophilia of pregnancy mimicking angiosarcoma.

J. Messina, J. Zager, Iriana P Bélongie, 2011, Cutis.

Advances in Intralesional Therapy for Locoregionally Advanced and Metastatic Melanoma: Five Years of Progress

J. Zager, D. DePalo, 2023, Cancers.

Management of Locoregionally Advanced Melanoma.

J. Zager, D. Pointer, 2020, The Surgical clinics of North America.

Intralesional Therapies: Oncolytic Viral Therapies, Immunostimulants

J. Zager, J. Miura, 2019 .

Intralesional therapy as a treatment for locoregionally metastatic melanoma

J. Zager, J. Miura, 2018, Expert review of anticancer therapy.

Locoregional therapies in melanoma.

A. Abbott, J. Zager, 2014, The Surgical clinics of North America.

Recurrence Patterns for Regionally Metastatic Melanoma Treated in the Era of Adjuvant Therapy: A Systematic Review and Meta-Analysis

M. Schabath, J. Pérez-Morales, J. Zager, 2022, Annals of Surgical Oncology.

Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases From an International Multicenter Study: Implications for the Management of American Joint Committee on Cancer IIIA Disease

V. Sondak, R. Scolyer, I. Johansson, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Multicenter Phase I Dose Escalation Trial to Evaluate Safety and Tolerability of Intra-arterial Temozolomide for Patients with Advanced Extremity Melanoma Using Normothermic Isolated Limb Infusion

M. Ross, C. Augustine, D. Tyler, 2014, Annals of Surgical Oncology.

A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.

M. Ross, A. Caudle, K. Delman, 2009, Journal of the American College of Surgeons.

A Multi-institutional Experience of Repeat Regional Chemotherapy for Recurrent Melanoma of Extremities

D. Tyler, S. Hochwald, S. Grobmyer, 2012, Annals of Surgical Oncology.

Isolated limb infusion for melanoma: a less morbid alternative to hyperthermic isolated limb perfusion in the US

J. Zager, A. Santillan, 2010, Expert opinion on drug metabolism & toxicology.

Predictive Factors of Regional Toxicity and Serum Creatine Phosphokinase Levels After Isolated Limb Infusion for Melanoma: A Multi-Institutional Analysis

M. Ross, K. Delman, D. Tyler, 2009, Annals of Surgical Oncology.

Burden of Disease Predicts Response to Isolated Limb Infusion with Melphalan and Actinomycin D in Melanoma

D. Tyler, Z. Thompson, J. Zager, 2014, Annals of Surgical Oncology.

Isolated regional therapy for advanced extremity soft tissue sarcomas.

J. Zager, J. Deneve, 2012, Surgical oncology clinics of North America.

Isolated Limb Infusion in a Series of Over 100 Infusions: A Single-Center Experience

J. Wong, K. Fisher, J. Zager, 2013, Annals of Surgical Oncology.

Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease

B. Stedman, Sanjay Gupta, A. Gangi, 2017, Journal of surgical oncology.

Developments in Intralesional Therapy for Metastatic Melanoma.

J. Zager, Sarah Sloot, Omar M Rashid, 2016, Cancer control : journal of the Moffitt Cancer Center.

Resection of Residual Disease after Isolated Limb Infusion (ILI) Is Equivalent to a Complete Response after ILI-Alone in Advanced Extremity Melanoma

D. Tyler, J. Wong, K. Fisher, 2014, Annals of Surgical Oncology.

Real-World Outcomes of Talimogene Laherparepvec Therapy: A Multi-Institutional Experience.

James X. Sun, K. Delman, D. Ollila, 2019, Journal of the American College of Surgeons.

Talimogene Laherparepvec (TVEC) for the Treatment of Advanced Melanoma: A Single-Institution Experience

J. Zager, A. Sarnaik, Youngchul Kim, 2018, Annals of Surgical Oncology.

A multi‐institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan‐based isolated limb infusion

M. Dewhirst, D. Tyler, J. Wong, 2012, Cancer.

Intra-arterial perfusion-based therapies for regionally metastatic cutaneous and uveal melanoma

J. Zager, K. Broman, 2019, Melanoma management.

Completion lymphadenectomy for a positive sentinel node biopsy in melanoma patients is not associated with a survival benefit

V. Sondak, H. Hoekstra, B. Pockaj, 2019, Journal of surgical oncology.

Future perspectives: cancer metastases

S. Leong, J. Zager, 2018, Clinical & Experimental Metastasis.

Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell Carcinoma

James X. Sun, V. Sondak, C. Slingluff, 2021, Annals of Surgical Oncology.

Sentinel lymph node biopsy for melanoma: indications and rationale.

V. Sondak, J. Messina, G. Phan, 2009, Cancer control : journal of the Moffitt Cancer Center.

Sentinel lymph node biopsy as the standard of care for cutaneous melanoma.

V. Sondak, J. Thomas, J. Messina, 2007, Clinical advances in hematology & oncology : H&O.

Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: A single institution experience

Junsung Choi, J. Zager, O. Rashid, 2014, Journal of surgical oncology.

A Multicenter Prospective Evaluation of the Clinical Utility of F-18 FDG-PET/CT in Patients With AJCC Stage IIIB or IIIC Extremity Melanoma

A. Abernethy, D. Tyler, G. Broadwater, 2012, Annals of surgery.

Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging

R. Elashoff, D. Elashoff, A. Cochran, 2019, Annals of surgery.

Resection of Gastrointestinal Metastases in Stage IV Melanoma: Correlation with Outcomes

V. Sondak, R. Gonzalez, G. Gibney, 2016, The American surgeon.

Robotic-Assisted Pelvic Lymphadenectomy for Metastatic Melanoma Results in Durable Oncologic Outcomes

James X. Sun, Lesly A. Dossett, J. Zager, 2019, Annals of Surgical Oncology.

Is pelvic sentinel node biopsy necessary for lower extremity and trunk melanomas?

A. Dueck, M. Kashani-Sabet, S. Leong, 2017, American journal of surgery.

Routine biopsy of cloquet's node is of limited value in sentinel node positive melanoma patients

V. Sondak, K. Delman, J. Messina, 2010, Journal of surgical oncology.

Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection

James X. Sun, Lesly A. Dossett, T. Hieken, 2022, Journal for ImmunoTherapy of Cancer.

Cutaneous leiomyosarcoma: treatment and outcomes with a standardized margin of resection.

V. Sondak, R. Gonzalez, M. Bui, 2013, Cancer control : journal of the Moffitt Cancer Center.

A phase III random assignment trial comparing percutaneous hepatic perfusion with melphalan (PHP-mel) to standard of care for patients with hepatic metastases from metastatic ocular or cutaneous melanoma.

C. Nutting, H. Alexander, M. Hughes, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Performance of a 31‐gene expression profile test in cutaneous melanomas of the head and neck

K. Covington, J. Wayne, J. Messina, 2019, Head & neck.

Locoregional melanoma: identifying optimal care in a rapidly changing landscape

J. Zager, D. Gyorki, 2019, Melanoma management.

An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma

James X. Sun, V. Sondak, C. Slingluff, 2022, Annals of Surgical Oncology.

Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanoma

J. Nemunaitis, John W Walker, Cheng-Pang Hsu, 2019, EBioMedicine.

Single-institution Outcome Experience Using AlloDerm® as Temporary Coverage or Definitive Reconstruction for Cutaneous and Soft Tissue Malignancy Defects

V. Sondak, R. Gonzalez, J. Zager, 2013, The American surgeon.

Factors predicting survival in thick melanoma: Do all thick melanomas have the same prognosis?

V. Sondak, B. Pockaj, M. Kashani-Sabet, 2020, Surgery.

Re-biopsy of partially sampled thin melanoma impacts sentinel lymph node sampling as well as surgical margins

V. Sondak, R. Gonzalez, J. Messina, 2019, Melanoma management.

Behavior of Cutaneous Adnexal Malignancies: a Single Institution Experience

V. Sondak, J. Messina, B. Yue, 2018, Pathology & Oncology Research.

Full-Thickness Grafts Procured from Skin Overlying the Sentinel Lymph Node Basin; Reconstruction of Primary Cutaneous Malignancy Excision Defects

V. Sondak, Daohai Yu, D. Reintgen, 2008, Annals of Surgical Oncology.

Management of intussusception in patients with melanoma

James X. Sun, V. Sondak, R. Gonzalez, 2019, Journal of surgical oncology.

Identifying risk factors using a skin cancer screening program.

V. Sondak, M. Schell, J. Messina, 2013, Cancer control : journal of the Moffitt Cancer Center.

What is the Significance of the In Transit or Interval Sentinel Node in Melanoma?

V. Sondak, J. Zager, C. Puleo, 2011, Annals of Surgical Oncology.

Quality of life patient-reported outcomes for locally advanced cutaneous melanoma

C. Gwaltney, Mona L. Martin, J. Zager, 2017, Melanoma research.

Isolated hepatic perfusion for metastatic melanoma

J. Zager, Maki Yamamoto, 2014, Journal of surgical oncology.

ASO Author Reflection: Isolated Limb Infusion for Locally Advanced Melanoma in the Extremely Old Patient is Safe and Effective

J. Zager, H. Kroon, J. Teras, 2020, Annals of Surgical Oncology.

Up‐regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a γ134.5 deleted oncolytic herpes virus (G207)

Prasad Adusumilli, Yuman Fong, T. Chou, 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Efficacy of Multiagent Herpes Simplex Virus Amplicon-Mediated Immunotherapy as Adjuvant Treatment for Experimental Hepatic Cancer

K. Delman, M. Halterman, P. Mcauliffe, 2002, Annals of surgery.

Chemosaturation with Percutaneous Hepatic Perfusion for Unresectable Isolated Hepatic Metastases from Sarcoma

R. Gonzalez, Junsung Choi, J. Zager, 2012, CardioVascular and Interventional Radiology.

9304 ORAL Percutaneous Hepatic Perfusion (PHP) Vs. Best Alternative Care (BAC) for Patients (pts) With Melanoma Liver Metastases – Efficacy Update of the Phase 3 Trial (NCT00324727)

C. Nutting, H. Alexander, M. Hughes, 2011 .

Use of radiolabelled iododeoxyuridine as adjuvant treatment for experimental tumours of the liver

K. Delman, Y. Fong, M. Ebright, 2003, British Journal of Surgery.

Effects of preexisting immunity on the response to herpes simplex-based oncolytic viral therapy.

K. Delman, P. Mcauliffe, Y. Fong, 2000, Human gene therapy.

Commentary on pharmacotherapy of regional melanoma therapy

K. Delman, J. Zager, 2010, Expert opinion on pharmacotherapy.

Atypical Fibroxanthoma: Outcomes from a Large Single Institution Series

V. Sondak, J. Messina, J. Zager, 2023, Cancer Control: Journal of the Moffitt Cancer Cente.

A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology

C. Elmets, A. Cochran, C. McLaren, 2014, Cancer Prevention Research.

A Randomized, Double-Blind, Placebo-Controlled Phase II ClinicalTrialofLovastatinforVariousEndpointsofMelanoma Pathobiology

C. Elmets, A. Cochran, C. McLaren, 2014 .

A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for VariousEndpoints ofMelanoma Pathobiology

C. Elmets, A. Cochran, C. McLaren, 2014 .

Pathobiology Clinical Trial of Lovastatin for Various Endpoints of Melanoma A Randomized , Double-Blind , Placebo-Controlled Phase II

C. Elmets, A. Cochran, C. McLaren, 2014 .

Endovascular repair of a traumatic pseudoaneurysm of the thoracic aorta in a patient with concomitant intracranial and intra-abdominal injuries.

F. Veith, R. Simon, J. Zager, 2003, The Journal of trauma.

Chemosaturation for primary and secondary liver malignancies: A comprehensive update of current evidence.

A. Vogel, J. Zager, A. Saborowski, 2022, Cancer treatment reviews.

Percutaneous hepatic perfusion (PHP) with melphalan for patients with ocular melanoma liver metastases: Preliminary results of FOCUS (PHP-OCM-301/301A) phase III trial.

A. Gesierich, A. Ejaz, R. Dummer, 2021 .

Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection

W. Jarnagin, K. Delman, D. Klimstra, 2003, Cancer Gene Therapy.

Robotic-Assisted Transperitoneal Pelvic Lymphadenectomy for Metastatic Melanoma: Early Outcomes Compared with Open Pelvic Lymphadenectomy.

Lesly A. Dossett, V. Sondak, J. Pow-Sang, 2016, Journal of the American College of Surgeons.

ASO Author Reflections: Robotic Pelvic Lymph Node Dissection for Metastatic Melanoma—A Minimally Invasive Approach to a Difficult Problem

J. Zager, J. Miura, 2019, Annals of Surgical Oncology.

International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers

James X. Sun, Lesly A. Dossett, V. Sondak, 2022, Annals of surgery.

Progression of cutaneous melanoma: implications for treatment

A. Hauschild, V. Sondak, M. Mihm, 2012, Clinical & Experimental Metastasis.

Metastasectomy for Abdominal Visceral Oligometastatic Melanoma.

J. Zager, D. DePeralta, 2017, JAMA surgery.

Multidisciplinary Management in Primary and Metastatic Melanoma

J. Zager, 2010 .

The Surgeons’ Role When Systemic Therapies Fail in Metastatic Melanoma: The Salvage Metastasectomy

J. Zager, 2021, Annals of Surgical Oncology.

Neoadjuvant BRAF‐targeted therapy in regionally advanced and oligometastatic melanoma

V. Sondak, J. Messina, J. Markowitz, 2020, Pigment cell & melanoma research.

Isolated Limb Infusion for Limb-Threatening, Unresectable Sarcoma: Past Progress, Current Applications, and Future Directions

J. Zager, D. DePalo, 2023, Journal of clinical medicine.

Sentinel Lymph Node Biopsy in Patients with T1a Cutaneous Malignant Melanoma: A Multi-Center Cohort Study.

V. Sondak, A. Sinnamon, J. Zager, 2022, Journal of the American Academy of Dermatology.

Current standards of surgical management in primary melanoma.

J. Zager, S. Orcutt, M. Perez, 2018, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

An Update on Talimogene Laherparepvec

J. Zager, M. Doepker, 2016 .

Great Debate: Limb Infusion for Melanoma: A Thing of the Past?

J. Zager, G. Beasley, K. Rhodin, 2023, Annals of surgical oncology.

A prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion (M-ILI) in patients with advanced extremity melanoma.

M. Ross, D. Tyler, S. Hochwald, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intraperitoneal Rosai-Dorfman disease associated with clear cell sarcoma: first case report.

J. Messina, J. Zager, J. Hassani, 2016, Pathology.

Isolated Limb Infusion for Melanoma

P. Kam, J. Zager, P. Lindnér, 2018, Cutaneous Melanoma.

External Validation of a Dutch Predictive Nomogram for Complete Response to T-VEC in an Independent American Patient Cohort

J. Zager, A. V. van Akkooi, E. Stahlie, 2021, Annals of Surgical Oncology.

Local and Recurrent Regional Metastases of Melanoma

C. Ariyan, K. Tanabe, J. Zager, 2020, Cutaneous Melanoma.

Regional therapies for locoregionally advanced and unresectable melanoma

J. Zager, E. Weitman, 2018, Clinical & Experimental Metastasis.

encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy

James X. Sun, J. Zager, Z. Eroglu, 2018 .

A safety review of recently approved and late-stage trial treatments for metastatic melanoma: systemic and regional therapies.

J. Zager, D. DePalo, M. Perez, 2023, Expert Opinion on Drug Safety.

Improving clinical outcomes with pembrolizumab in patients with advanced melanoma.

J. Zager, Z. Eroglu, Dae Won Kim, 2017, Chinese clinical oncology.

1123P A phase Ib study of rose bengal disodium and anti-PD-1 in metastatic cutaneous melanoma: Initial results in patients refractory to checkpoint blockade

M. Ross, R. Essner, K. Shirai, 2020 .

Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?

S. H. A. Chen, M. Iyer, D. Tyler, 2023, Annals of surgical oncology.

Recent developments in the medical and surgical treatment of melanoma

R. Kudchadkar, J. Zager, C. Ambe, 2014, CA: a cancer journal for clinicians.

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.

G. Linette, M. Ross, K. Harrington, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Regional therapy in metastatic melanoma: an update on minimally invasive intraarterial isolated limb infusion and percutaneous hepatic perfusion

J. Zager, S. Sloot, O. Rashid, 2014, Expert opinion on drug metabolism & toxicology.

Isolated Limb Perfusion and Infusion for Extremity Soft Tissue Sarcoma: A Contemporary Systematic Review and Meta-Analysis

D. Fraker, A. Sinnamon, J. Zager, 2017, Annals of Surgical Oncology.

Isolated Limb Infusion: A Single-Center Experience with Over 200 Infusions

R. Gonzalez, J. Zager, Youngchul Kim, 2017, Annals of Surgical Oncology.

Review of diagnostic, prognostic, and predictive biomarkers in melanoma

J. Messina, J. Luke, J. Zager, 2018, Clinical & Experimental Metastasis.

Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma.

Jacob G. Scott, R. Gonzalez, M. Bui, 2016, Brachytherapy.

Multimodality management of desmoid tumors: How important is a negative surgical margin?

V. Sondak, J. Zager, M. Melis, 2008, Journal of surgical oncology.

Analysis of Tumor Mitotic Rate in Thin Metastatic Melanomas Compared With Thin Melanomas Without Metastasis Using Both the Hematoxylin and Eosin and Anti-phosphohistone 3 IHC Stain

D. Jukic, J. Messina, Divya Sadhwani, 2014, The American Journal of dermatopathology.

Outcomes and clinical predictors of improved survival in a patients undergoing pulmonary metastasectomy for sarcoma

Lesly A. Dossett, R. Gonzalez, J. Zager, 2015, Journal of surgical oncology.

Prognostication in Merkel cell carcinoma

J. Messina, J. Zager, D. Rollison, 2011, Expert review of anticancer therapy.

Management of acral lentiginous melanoma: current updates and future directions

J. Zager, Michelle M. Dugan, Matthew C. Perez, 2024, Frontiers in oncology.

Talimogene Laherparepvec in Combination with Immunotherapy, A Viable Option?

J. Zager, A. V. van Akkooi, 2022, Annals of Surgical Oncology.

Grade of Primary Cutaneous Leiomyosarcoma Dictates Risk for Metastatic Spread and Disease-Specific Mortality

J. Zager, Michael J. Carr, J. Mullinax, 2023, Cancer control : journal of the Moffitt Cancer Center.

External Validation of a Dutch Predictive Nomogram for Complete Response to T-VEC in an Independent American Patient Cohort

J. Zager, A. V. van Akkooi, Michael J. Carr, 2021, Annals of Surgical Oncology.

Microsatellitosis in Patients with Melanoma

V. Sondak, P. Gimotty, B. Pockaj, 2018, Annals of Surgical Oncology.

Intralesional and Infusional Updates for Metastatic Melanoma

J. Zager, A. Shannon, D. DePalo, 2024, Cancers.

Isolated hyperthermic perfusions for cutaneous melanoma in-transit metastasis of the limb and uveal melanoma metastasis to the liver.

J. Zager, R. Olofsson Bagge, D. DePalo, 2023, Clinical & experimental metastasis.

Isolated Limb Infusion for Melanoma

J. Zager, H. Kroon, D. S. Tyler, 2018, Cutaneous Melanoma.

Isolated Limb Infusion for Melanoma

J. Zager, H. Kroon, D. S. Tyler, 2020, Cutaneous Melanoma.

Radar-Guided Localization and Resection for Metastatic Nodal and Soft Tissue Melanoma: A Single-Institution Retrospective Study

V. Sondak, J. Zager, A. Sarnaik, 2024, Cancer control : journal of the Moffitt Cancer Center.